×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BCRX – biocryst pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BCRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/27
12:00 am
bcrx
Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]
High
Report
Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]
2/26
04:42 pm
bcrx
BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
Medium
Report
BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]
2/26
07:32 am
bcrx
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
07:00 am
bcrx
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
Low
Report
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
2/25
01:39 pm
bcrx
Are BioCryst Pharmaceuticals (BCRX) Shares Offering Value After Recent Price Rebound [Yahoo! Finance]
Low
Report
Are BioCryst Pharmaceuticals (BCRX) Shares Offering Value After Recent Price Rebound [Yahoo! Finance]
2/18
08:43 am
bcrx
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Medium
Report
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
2/17
07:00 am
bcrx
BioCryst to Present at Upcoming Investor Conference
Low
Report
BioCryst to Present at Upcoming Investor Conference
2/11
07:00 am
bcrx
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
Medium
Report
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
2/26/2026
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
0.9%
biocryst pharmaceuticals, inc.
11/3/2025
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
-3.2%
biocryst pharmaceuticals, inc.
8/4/2025
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
3.9%
biocryst pharmaceuticals, inc.
5/5/2025
07:00 am
BCRX
biocryst pharmaceuticals, inc.
BEAT
Report
16.6%
biocryst pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
2/26
04:05 pm
bcrx
Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31
Medium
Report
Form 10-K BIOCRYST PHARMACEUTICALS For: Dec 31
2/26
07:20 am
bcrx
Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 26
Low
Report
Form 8-K BIOCRYST PHARMACEUTICALS For: Feb 26
2/12
02:17 pm
bcrx
Form SCHEDULE 13G/A BIOCRYST PHARMACEUTICALS Filed by: Flynn James E
Low
Report
Form SCHEDULE 13G/A BIOCRYST PHARMACEUTICALS Filed by: Flynn James E
2/9
06:20 am
bcrx
Form SCHEDULE 13G BIOCRYST PHARMACEUTICALS Filed by: STATE STREET CORP
Low
Report
Form SCHEDULE 13G BIOCRYST PHARMACEUTICALS Filed by: STATE STREET CORP
1/27
05:23 pm
bcrx
Form 4 BIOCRYST PHARMACEUTICALS For: Jan 23 Filed by: Milne Jill C.
Low
Report
Form 4 BIOCRYST PHARMACEUTICALS For: Jan 23 Filed by: Milne Jill C.
1/27
05:19 pm
bcrx
Form 3 BIOCRYST PHARMACEUTICALS For: Jan 23 Filed by: Milne Jill C.
Low
Report
Form 3 BIOCRYST PHARMACEUTICALS For: Jan 23 Filed by: Milne Jill C.
1/23
04:32 pm
bcrx
Form 8-K/A BIOCRYST PHARMACEUTICALS For: Oct 14
Low
Report
Form 8-K/A BIOCRYST PHARMACEUTICALS For: Oct 14
1/23
04:30 pm
bcrx
Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 23
Low
Report
Form 8-K BIOCRYST PHARMACEUTICALS For: Jan 23
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/18
Form 4 BIOCRYST PHARMACEUTICALS For: Nov 18 Filed by: Babu Yarlagadda S
19.8%
3/3 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: LEVIN ALAN G 15.1%
5/29 Form SC 13G BIOCRYST PHARMACEUTICALS Filed by: INTEGRATED CORE STRATEGIES (US) LLC 14.7%
4/9 BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19 13.5%
9/23 BioCryst Appoints Helen Thackray, M.D., to Board of Directors 12.9%
2/25 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 21 Filed by: Jones Michael L 11.9%
3/13 BioCryst Pharmaceuticals: Multiple Value Drivers With A Coronavirus Kicker [Seeking Alpha] 11.9%
1/26 5 Biotech Stocks to Watch With the Coronavirus Scare [The Motley Fool] 11.1%
3/19 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 11.0%
4/23 BioCryst feels Gilead's remdesivir pain, down 9% [Seeking Alpha] 10.6%
3/3 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 27 Filed by: LEVIN ALAN G 15.1%
5/29 Form SC 13G BIOCRYST PHARMACEUTICALS Filed by: INTEGRATED CORE STRATEGIES (US) LLC 14.7%
4/9 BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19 13.5%
9/23 BioCryst Appoints Helen Thackray, M.D., to Board of Directors 12.9%
2/25 Form 4 BIOCRYST PHARMACEUTICALS For: Feb 21 Filed by: Jones Michael L 11.9%
3/13 BioCryst Pharmaceuticals: Multiple Value Drivers With A Coronavirus Kicker [Seeking Alpha] 11.9%
1/26 5 Biotech Stocks to Watch With the Coronavirus Scare [The Motley Fool] 11.1%
3/19 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 11.0%
4/23 BioCryst feels Gilead's remdesivir pain, down 9% [Seeking Alpha] 10.6%
TOP News Decliners
5/20
Form 4 BIOCRYST PHARMACEUTICALS For: May 16 Filed by: STAAB THOMAS R II
-52.9%
3/9 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -34.2%
3/10 Form 8-K BIOCRYST PHARMACEUTICALS For: Mar 04 -23.2%
3/16 BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2 -19.7%
4/9 BioCryst stock rallies on start of coronavirus drug study [MarketWatch] -19.0%
12/11 Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 11 -10.4%
1/12 BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference -10.1%
1/27 Why BioCryst Pharmaceuticals Stock Is Jumping Again Today [The Motley Fool] -10.0%
2/25 BioCryst Appoints Alan G. Levin to Board of Directors -9.4%
5/24 Form 4 BIOCRYST PHARMACEUTICALS For: May 22 Filed by: ASELAGE STEVE -9.2%
3/9 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -34.2%
3/10 Form 8-K BIOCRYST PHARMACEUTICALS For: Mar 04 -23.2%
3/16 BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2 -19.7%
4/9 BioCryst stock rallies on start of coronavirus drug study [MarketWatch] -19.0%
12/11 Form 8-K BIOCRYST PHARMACEUTICALS For: Dec 11 -10.4%
1/12 BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference -10.1%
1/27 Why BioCryst Pharmaceuticals Stock Is Jumping Again Today [The Motley Fool] -10.0%
2/25 BioCryst Appoints Alan G. Levin to Board of Directors -9.4%
5/24 Form 4 BIOCRYST PHARMACEUTICALS For: May 22 Filed by: ASELAGE STEVE -9.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: